T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note published on Wednesday. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

TTOO stock opened at $0.22 on Wednesday. T2 Biosystems has a 52-week low of $0.21 and a 52-week high of $6.95. The company’s 50-day simple moving average is $0.38 and its 200-day simple moving average is $1.82.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.